Log in | Register

Home
All Journals
Expert Review of Pharmacoeconomics & Outcomes Research
List of Issues
Volume 12, Issue 6

Expert Review of Pharmacoeconomics & Outcomes Research

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Review of Pharmacoeconomics & Outcomes Research, Volume 12, Issue 6 (2012)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Pharmacoeconomics & Outcomes Research, Volume 12, Issue 6 (2012)

See all volumes and issues

Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Volume 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Article

A reference pricing system for Ireland

Cara Usher & Michael Barry

Pages: 675-677

Published online: 09 Jan 2014

First Page PreviewforA reference pricing system for Ireland | Full Text | References | PDF (667.4 KB)

655 Views
1 CrossRef citations
0Altmetric

Free Access

News in brief

Article

News in brief

Pages: 679-681

Published online: 09 Jan 2014

First Page PreviewforNews in brief | Full Text | PDF (612.2 KB)

15 Views
0 CrossRef citations
0Altmetric

Drug Profile

Article

Cost–effectiveness of linezolid in methicillin-resistant Staphylococcus aureus skin and skin structure infections

Mark Bounthavong & Donald I Hsu

Pages: 683-698

Published online: 09 Jan 2014

AbstractforCost–effectiveness of linezolid in methicillin-resistant Staphylococcus aureus skin and skin structure infections | Full Text | References | PDF (1,001.3 KB)

282 Views
9 CrossRef citations
0Altmetric

Article

Pegfilgrastim: a review of the pharmacoeconomics for chemotherapy-induced neutropenia

Pierre Rofail, Mariam Tadros, Riham Ywakim, Mina Tadrous, Allison Krug & Leon E Cosler

Pages: 699-709

Published online: 09 Jan 2014

AbstractforPegfilgrastim: a review of the pharmacoeconomics for chemotherapy-induced neutropenia | Full Text | References | PDF (994.7 KB)

178 Views
8 CrossRef citations
0Altmetric

Perspective

Article

The changing role of economic evaluation in valuing medical technologies

Jason S Rotter, Douglas Foerster & John FP Bridges

Pages: 711-723

Published online: 09 Jan 2014

AbstractforThe changing role of economic evaluation in valuing medical technologies | Full Text | References | PDF (415.6 KB)

244 Views
13 CrossRef citations
0Altmetric

Review

Article

Delivering cost–effective care for COPD in the USA: recent progress and current challenges

Ian M Breunig, Fadia T Shaya & Steven M Scharf

Pages: 725-731

Published online: 09 Jan 2014

AbstractforDelivering cost–effective care for COPD in the USA: recent progress and current challenges | Full Text | References | PDF (871.6 KB)

169 Views
14 CrossRef citations
0Altmetric

Article

Combating pediatric obesity in Germany: the role of economic findings in informing policy

Jürgen John & Christina M Teuner

Pages: 733-743

Published online: 09 Jan 2014

AbstractforCombating pediatric obesity in Germany: the role of economic findings in informing policy | Full Text | References | PDF (913.4 KB)

104 Views
3 CrossRef citations
0Altmetric

Article

Cognitive behavior therapy via the Internet: a systematic review of applications, clinical efficacy and cost–effectiveness

Erik Hedman, Brjánn Ljótsson & Nils Lindefors

Pages: 745-764

Published online: 09 Jan 2014

AbstractforCognitive behavior therapy via the Internet: a systematic review of applications, clinical efficacy and cost–effectiveness | Full Text | References | PDF (1.1 MB)

5796 Views
451 CrossRef citations
0Altmetric

Article

Hepatitis C virus in Asia: utility values based on the Short Form-36 questionnaire

Bruce Crawford, Chi-Kit Yeung, Erika Tanaka, Matthias Kraemer & Claudia Leteneux

Pages: 765-773

Published online: 09 Jan 2014

AbstractforHepatitis C virus in Asia: utility values based on the Short Form-36 questionnaire | Full Text | References | PDF (977.7 KB)

72 Views
3 CrossRef citations
0Altmetric

Article

The cost offsets and cost–effectiveness associated with pegylated drugs: a review of the literature

Russell Becker, Carole Dembek, Leigh Ann White & Louis P Garrison

Pages: 775-793

Published online: 09 Jan 2014

AbstractforThe cost offsets and cost–effectiveness associated with pegylated drugs: a review of the literature | Full Text | References | PDF (855.5 KB)

204 Views
19 CrossRef citations
0Altmetric

Article

When a parent has cancer: challenges to patients, their families and health providers

Kerstin Krauel, Andrea Simon, Nadine Krause-Hebecker, Agnes Czimbalmos, Andrew Bottomley & Henning Flechtner

Pages: 795-808

Published online: 09 Jan 2014

AbstractforWhen a parent has cancer: challenges to patients, their families and health providers | Full Text | References | PDF (930.1 KB)

367 Views
33 CrossRef citations
0Altmetric

Primary Research

Article

Influence of lifting prescribing restrictions for losartan on subsequent sartan utilization patterns in Austria: implications for other countries

Anna Bucsics, Brian Godman, Thomas Burkhardt, Manuela Schmitzer & Rickard E Malmström

Pages: 809-819

Published online: 09 Jan 2014

AbstractforInfluence of lifting prescribing restrictions for losartan on subsequent sartan utilization patterns in Austria: implications for other countries | Full Text | References | PDF (3.4 MB)

48 Views
13 CrossRef citations
0Altmetric

Article

The effect of gout on health-related quality of life, work productivity, resource use and clinical outcomes among patients with hypertension

Marco daCosta DiBonaventura, Laquesha M Andrews, Anthony M Yadao & Kristijan H Kahler

Pages: 821-829

Published online: 09 Jan 2014

AbstractforThe effect of gout on health-related quality of life, work productivity, resource use and clinical outcomes among patients with hypertension | Full Text | References | PDF (942.4 KB)

167 Views
17 CrossRef citations
0Altmetric

Research Report

Article

Quality of life in patients with primary and metastatic brain cancer as reported in the literature using the EORTC QLQ-BN20 and QLQ-C30

Leonard Chiu, Nicholas Chiu, Liang Zeng, Liying Zhang, Marko Popovic, Ronald Chow, Henry Lam, Michael Poon & Edward Chow

Pages: 831-837

Published online: 09 Jan 2014

AbstractforQuality of life in patients with primary and metastatic brain cancer as reported in the literature using the EORTC QLQ-BN20 and QLQ-C30 | Full Text | References | PDF (901 KB)

333 Views
24 CrossRef citations
0Altmetric

Appendices

Article

Acknowledgements

Page: 839

Published online: 09 Jan 2014

CitationforAcknowledgements | Full Text | PDF (454.4 KB)

185 Views
0 CrossRef citations
0Altmetric

Free Access

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Cost-effectiveness analysis of atezolizumab plus bevacizumab compared with sorafenib as first-line treatment in advanced hepatocellular carcinoma in Singapore

Cheng Ean Chee et al.

Article | Published online: 22 May 2024

Quality-adjusted life years for HER2-positive, early-stage breast cancer using trastuzumab-containing regimens in the context of cost-effectiveness studies: a systematic review

Sudewi Mukaromah Khoirunnisa et al.

Review Article | Published online: 20 May 2024

Open Access

Economic evaluation of stereotactic radiotherapy and stereotactic radiosurgery technologies in the treatment of cancers: a systematic review

Aziz Rezapour et al.

Review Article | Published online: 20 May 2024

Unlocking the full potential of digital endpoints for decision making: a novel modular evidence concept enabling re-use and advancing collaboration

Lada Leyens et al.

Review Article | Published online: 15 May 2024

Open Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Review of Pharmacoeconomics & Outcomes Research (Vol.12, Iss.6, 2012)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?